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Objectives: a relationship has been demonstrated between increased intestinal permeability, endotoxaemia and the
development of the systemic inflammatory response syndrome (SIRS) after aortic surgery. The aim of this study was to
evaluate whether isolated lower limb ischaemia-reperfusion (I/R) injury affects intestinal mucosal barrier function and
cytokine release.
Patients and Methods: four groups of patients were investigated, group I, patients with critical limb ischaemia (CLI)
undergoing infra-inguinal bypass surgery (n 18); group II, patients with intermittent claudication (IC) undergoing
infra-inguinal bypass surgery (n 14); group III, patients with CLI unsuitable for arterial reconstruction, undergoing
major amputation (n 12); and group IV, patients undergoing carotid endarterectomy for symptomatic carotid stenosis
(n 13). Intestinal permeability, endotoxaemia and urinary soluble tumour necrosis factor receptors were assessed
(p55TNF-R).
Results: an increase in intestinal permeability was observed on the 3rd postoperative day only in CLI group. This was
found to correlate with arterial clamp time. Patients who had a femoro-distal bypass had significantly higher intestinal
permeability compared to those who had femoro-popliteal bypass. Endotoxaemia was not detected in any of the groups.
Postoperative urinary p55TNF-R concentrations were significantly higher in CLI group compared to the other groups.
These did not correlate with the increased intestinal permeability.
Conclusions: our results support the hypothesis that revascularisation of critically ischaemia limbs leads to intestinal
mucosal barrier dysfunction and cytokine release. They also suggest that the magnitude of the inflammatory response
following I/R injury is related to the degree of initial ischaemia.
Key Words: Ischaemia; Reperfusion injury; Permeability; Sepsis syndrome.
Introduction
The involvement of the gastrointestinal tract in
ischaemia-reperfusion (I/R) injury is of interest not
only because it functions as a target organ but also as
a potential effector of the multiple organ dysfunction
associated with reperfusion injury.1,2 When impaired,
the gut mucosa allows translocation of bacteria and
their toxins into the extraintestinal tissues and pro-
duces free radicals and cytokines that potentiate the
development of multiple organ dysfunction.3±6
Increased intestinal permeability with portal endo-
toxaemia and cytokine release has been observed after
repair of elective and ruptured abdominal aortic
aneurysms (AAA).7±9 I/R injury has been suggested
as an aetiological factor, with increased intestinal
permeability occurring because of hypovolaemia and
aortic clamping. However other workers have found
mucosal barrier dysfunction only after transperitoneal
repair of AAA and not with the extraperitoneal
approach, suggesting that intestinal manipulation
and mesenteric traction are more important factors.10
Increased intestinal permeability has also been
observed in patients with intermittent claudication
after exercise, which may be reversed after arterial revas-
cularisation. Repeated attacks of low-grade I/R injury
during exercise in these patients have been suggested as
the cause of the loss of intestinal mucosal integrity.11
In experimental models, isolated lower extremity
I/R injury has been found to be associated with
structural changes in the mucosa associated with
increased intestinal permeability, release of IL-6, endo-
toxaemia, and higher mortality.12,13
The role of the mucosal barrier in the development
of a systemic inflammatory response after isolated
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lower limb ischaemia-reperfusion injury has not so far
been examined in a clinical setting. The objective of
this study was, therefore, to evaluate the effect of
isolated lower limb I/R injury on intestinal mucosal
barrier function and the development of endotoxae-
mia and cytokine release in patients with varying
degrees of limb ischaemia.
Materials and Methods
Four groups of patients admitted for elective surgery
in the Vascular Surgery Unit, Belfast City Hospital
were studied prospectively after informed written
consent:
 Group I: patients undergoing infra-inguinal bypass
surgery for critical limb ischaemia (CLI).
 Group II: patients undergoing infra-inguinal bypass
surgery for disabling intermittent claudication (IC).
 Group III: patients with critical limb ischaemia,
unsuitable for reconstructive surgery, undergoing
above or below knee amputation.
 Group IV: patients undergoing carotid endarterect-
omy (CEA) for symptomatic carotid stenosis
(control).
For the purpose of this study CLI was defined as
chronic ischaemia with persistent rest pain requiring
analgesia for more than 2 weeks, ulceration, gangrene
of the foot, or an ankle systolic pressure below
50 mmHg. Disabling claudication was defined as
short distance IC interfering with the patient's life
style. Patients in group III were considered unsuitable
for reconstructive surgery by a consultant vascular
surgeon on the basis of angiographic findings or clin-
ically after failure of previous bypass surgery. The
study was approved by the Research Ethics Commit-
tee of The Queen's University of Belfast.
Patients were excluded from the study if they had a
history of vasculitis, arterial lesions involving the
abdominal aorta or the iliac arteries, large ischaemic
ulcers 42 cm, infected ulcers, uncontrolled diabetes
mellitus (blood glucose 412 mmol/L on admission),
chronic renal failure (serum creatinine 4200 mmol/L
on admission), inflammatory bowel disease, other
chronic inflammatory disorders or Methicillin Resist-
ant Staphylococcus Aureus (MRSA) infection. Patients
undergoing CEA for carotid stenosis were also
excluded if they had IC or CLI.
Intestinal permeability
Intestinal permeability was assessed preoperatively
(PO), at day 1 (D1), day 3 (D3) and day 7 (D7) by
measuring the urinary excretion of orally adminis-
tered lactulose and mannitol. Patients were fasted for
6 h before the test and a pre-test urine sample was
obtained. A test solution consisting of 10 g of lactulose
and 5 g of mannitol mixed in 100 ml of water was
administered orally. All urine was then collected for
6 h and refrigerated. At the completion of the collec-
tion, the urine was divided into aliquots and frozen at
ÿ20 C until assayed.
The concentrations of lactulose and mannitol were
measured enzymatically by reduced nicotinamide
adenine dinucleotide (phosphate)-linked enzymatic
assay, using a Cobras Fara centrifugal analyzer
(Roche Diagnostics, Welwyn Garden City, U.K.).14,15
Interference from glucose in the lactulose assay was
overcome by incubating the sample with glucose
oxidase and catalase for 3 h at 37 C before lactulose
analysis.16 Inter and intra-assay coefficients of
variation were 55%.
Blood samples
Five ml of systemic blood was collected into
endotoxin-free (Falcon 111548, Labtech International
Ltd, Sussex, U.K.) heparinised (20 iu/ml of blood)
tubes from a peripheral vein in the anticubital fossa.
In the CLI & IC groups, samples were collected imme-
diately before arterial clamping (PC), at maximum
ischaemia (IS), immediately and 1 h after reperfusion
and then daily at 8 am for 7 days. For the amputation
group, samples were collected preoperatively (PO),
1 h after amputation and then daily as above. For the
CEA group, samples were collected PO, 1 h postopera-
tively and then daily for 3 days. These samples were
centrifuged immediately at 500 g for 10 min at 4 C.
The plasma was then aliquoted into sterile endotoxin
free tubes (Nunc 363401, Intermed, Rosklide,
Denmark) and stored at ÿ70 C until assayed. Strict
aseptic techniques were maintained throughout the
handling of the samples.
Endotoxin measurements were made using the
chromogenic Limulus Amoebocyte Lysate (LAL) tech-
nique (Coatest Endotoxin, Quadratech, Epsom,
U.K.).17 Antiendotoxin antibodies were measured
using the EndoCAb assay, which measures the
concentrations of antibodies (IgG and IgM) to the
core region of the lipopolysaccharide molecule.18
Urine samples
Five ml of urine was collected at PO, D1, D3 and D7.
Urinary concentrations of p55TNF-R were measured
by an ELISA assay as described by Liabakk.19
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The relationship between endotoxaemia, increased
intestinal permeability, SIRS and MODS is still contro-
versial. Endotoxaemia and increased intestinal
permeability were reported after major vascular sur-
gery including abdominal aortic aneurysm repair.10
However, endotoxaemia was detected before and not
at the very moment of the documented increase in
intestinal permeability, with no temporal correlation
between them, indicating that endotoxaemia and
increased intestinal permeability may be independent
phenomena.10 On the other hand, endotoxaemia could
have contributed to the rise in the already abnormal
intestinal permeability. A single dose of endotoxin
may increase intestinal permeability in healthy volun-
teers.16 Other workers have detected systemic endo-
toxaemia in the immediate postoperative period
following major surgery without relation to subse-
quent complications and they further questioned
the relationship between endotoxaemia and the
development of MODS.7
The absence of relationship between systemic endo-
toxaemia and increased intestinal permeability in this
study agrees with the findings of other workers who
could not detect systemic endotoxaemia even after
aortic surgery inspite of increased intestinal permea-
bility.8,10 They also found no correlation between the
increased intestinal permeability and endotoxaemia or
between endotoxaemia and the development of
MODS. This may be explained by the fact that the
increased intestinal permeability was transient and
mild, and did not lead to endotoxaemia, or that sys-
temic endotoxaemia was intermittent and was not
detected because of the infrequent sampling times. In
this study, the increased intestinal permeability was
not accompanied by systemic endotoxaemia. How-
ever, other workers have found a significant correl-
ation between intestinal mucosal dysfunction and
portal endotoxaemia following aortic surgery even
though the portal endotoxaemia was only detected
intraoperatively and did not seem to be related to
the systemic endotoxaemia.10 In addition, the increase
in intestinal permeability was observed 24 h later.
Endotoxin works via the release of proinflammatory
mediators such as TNF-a. Unfortunately, the detection
of TNF-a, like endotoxin, in plasma following I/R
injury has been inconsistent due to its short half life,
burst-like release, limited frequency of sampling and
assaying techniques.30 These problems in detecting
TNF-a may be avoided if soluble p55TNF-R is mea-
sured. This is a more stable compound and urinary
p55TNF-R has been shown to be an accurate measure
of the systemic inflammatory state. In addition, mea-
suring urinary p55TNF-R has the advantage of avoid-
ing plasma inhibitors and haemodilution which can
interfere with plasma p55TNF-R measurements.31 In
the present study, the significantly greater p55TNF-R
response in CLI group implies a greater inflammatory
response in this group of patients. Unlike intestinal
permeability no difference was observed between
those undergoing femoro-distal bypass and those
who had femoro-popliteal bypass suggesting that the
inflammatory response may be influenced by the
degree of initial ischaemia.
In conclusion, these results suggest that intestinal
mucosal barrier dysfunction and cytokine response
following the revascularisation of chronic limb ischae-
mia may be related to the degree of initial ischaemia.
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